DS Healthcare Group (OTCMKTS: DSKX) and Nu Skin Enterprises (NYSE:NUS) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.
Institutional & Insider Ownership
0.0% of DS Healthcare Group shares are owned by institutional investors. Comparatively, 79.3% of Nu Skin Enterprises shares are owned by institutional investors. 19.4% of DS Healthcare Group shares are owned by insiders. Comparatively, 5.2% of Nu Skin Enterprises shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
This table compares DS Healthcare Group and Nu Skin Enterprises’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|DS Healthcare Group||-62.31%||-1,304.25%||-117.85%|
|Nu Skin Enterprises||6.97%||22.38%||10.29%|
Nu Skin Enterprises pays an annual dividend of $1.44 per share and has a dividend yield of 2.3%. DS Healthcare Group does not pay a dividend. Nu Skin Enterprises pays out 52.7% of its earnings in the form of a dividend. DS Healthcare Group has raised its dividend for 16 consecutive years.
Risk & Volatility
DS Healthcare Group has a beta of -0.21, indicating that its stock price is 121% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500.
Earnings & Valuation
This table compares DS Healthcare Group and Nu Skin Enterprises’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|DS Healthcare Group||$12.95 million||0.03||-$6.93 million||($0.28)||-0.05|
|Nu Skin Enterprises||$2.21 billion||1.52||$143.08 million||$2.73||23.32|
Nu Skin Enterprises has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.
This is a summary of current recommendations and price targets for DS Healthcare Group and Nu Skin Enterprises, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|DS Healthcare Group||0||0||0||0||N/A|
|Nu Skin Enterprises||2||2||2||0||2.00|
Nu Skin Enterprises has a consensus target price of $60.67, suggesting a potential downside of 4.69%. Given Nu Skin Enterprises’ higher probable upside, analysts plainly believe Nu Skin Enterprises is more favorable than DS Healthcare Group.
Nu Skin Enterprises beats DS Healthcare Group on 12 of the 15 factors compared between the two stocks.
About DS Healthcare Group
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system. The Pharmanex product line includes ageLOC Youth nutritional supplement, ageLOC TR90 weight management and body shaping system, and LifePak nutritional supplements. The Company has operations in various geographic regions, including Greater China, North Asia, Americas, South Asia/Pacific, and Europe, the Middle East and Africa (EMEA). It is focused on offering ageLOC Youth nutritional supplement and ageLOC Me personalized skin care system. The Company also offers household products and technology services.
Receive News & Ratings for DS Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.